0.17
0.17 (0%)
As of Apr 15, 2024
Motus Gi Holdings, Inc. [MOTS]
Source:
Company Overview
Motus Gi Holdings, Inc. have developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal endoscopy procedures and colonoscopies.
| Country | United States |
| Headquarters | ft. lauderdale, florida |
| Phone Number | (954) 541-8000 |
| Industry | manufacturing |
| CEO | Mark Pomeranz |
| Website | www.motusgi.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.3 |
| Operating Profit | $-11.9 |
| Net Income | $-12.9 |
| Net Cash | $-9.1 |
Profit Ratios
| Gross Margin | $-0.3 |
| Operating Margin | -3,732.6 |
| Profit as % of Revenues | 1.9% |
| Profit as % of Assets | -341.2% |
| Profit as % of Stockholder Equity | -478.9% |
Management Effectiveness
| Return on Equity | -478.9% |
| Return on Assets | -178.1% |
| Turnover Ratio | 8.5% |
| EBITA | $-11.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $7.2 |
| Total Liabilities | $4.5 |
| Operating Cash Flow | $-11.2 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $2.2 |
